Syncom Formulations (India) Ltd
NSE: SYNCOMF BSE: 524470
₹13.24
(-2.58%)
Thu, 19 Feb 2026, 09:04 am
Market Cap12.88B
PE Ratio18.05
Dividend0
Company History
1988
- Syncom Formulation (India) Ltd was established.
1995
- Syncom's state of art WHO-GMP and ISO 9001-2015 certified plant was established.
2005
- The company allotted 2.65 lakh fully paid-up equity shares on a preferential basis.
2006
- The Board of directors considered issuing 2.95 equity shares on a preferential basis.
- The company approved a plan to install two wind mills at Sangli in Maharashtra.
2008
- The Board of directors approved an amendment in the Articles of Association.
- The company allotted 3.1 lakh equity shares by way of preferential allotment.
- The company allotted 3.25 lakh warrants.
2009
- Syncom Formulations India recommended a dividend of Rs. 0.50 on equity shares of Rs. 10 each.
- Syncom Formulation (India) Ltd issued rights in the ratio of 1:2.
2011
- Mrs. Shikha Sethi was appointed as the Company Secretary of the Company.
2012
- The Company incorporated a Wholly Owned Subsidiary Company named 'TRADE ZONE FZE' in the United Arab Emirates.
- Shri. Praveen Jindal was appointed as an Independent Director of the company.
2013
- The Company announced a bonus in the ratio of 5:2.
- The Company split its face value from Rs 10 to Re. 1.
- The Company recommended a dividend of Rs. 0.60 per equity share of Rs. 10 each for the year 2012-13.
2014
- The Company recommended a dividend of Rs. 0.02 per equity share of Re. 1 each for the year 2013-14.
- Smt. Rinki Bankda was appointed as an Additional Director of the Company.
2022
- Syncom Formulations (India) Limited was awarded 'PRODUCT EXCELLENCE 2022' under the category of 'Pharma (Medium)'.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800